Lucid Diagnostics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	18.9	22.47	53.66	0.11	0.16
Cash & Cash Equivalents	18.9	22.47	53.66	0.11	0.16
Cash Growth	-15.92%	-58.11%	48238.74%	-29.03%	-
Receivables	0.05	0.02	0.2	0	0
Inventory	0.28	0.11	0	0	0
Other Current Assets	2.85	1.75	3.45	1.33	0.23
Total Current Assets	22.07	24.36	57.3	1.44	0.39
Property, Plant & Equipment	2.64	3.6	0.97	0	0
Goodwill and Intangibles	1.42	3.45	0	0	0
Other Long-Term Assets	1.13	1.11	0.73	0.76	0.64
Total Long-Term Assets	5.2	8.15	1.7	0.76	0.64
Total Assets	27.27	32.51	59	2.2	1.03
Accounts Payable	10.49	6.02	3.15	15.32	6.12
Current Debt	15.06	0.96	0	0	0
Other Current Liabilities	3.84	1.45	1.11	0.39	0.22
Total Current Liabilities	29.38	8.43	4.26	15.71	6.34
Long-Term Debt	0.2	1.04	0	0	0
Total Long-Term Liabilities	0.2	1.04	0	0	0
Total Liabilities	29.58	9.46	4.26	15.71	6.34
Total Debt	15.26	2	0	0	0
Debt Growth	663.13%	-	-	-	-
Retained Earnings	-150.74	-98.08	-41.9	-13.83	-5.55
Shareholders' Equity	-2.31	23.05	54.74	-13.52	-5.31
Net Cash / Debt	3.64	20.48	53.66	0.11	0.16
Net Cash / Debt Growth	-82.22%	-61.84%	48238.74%	-29.03%	-
Net Cash Per Share	0.09	0.57	2.88	0.01	0.02
Working Capital	-7.31	15.93	53.04	-14.27	-5.95
Book Value Per Share	-0.06	0.64	2.94	-0.96	-0.53

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).